Back to search
FDAFDA · Food and drugs·Recall number D-877-2014

MIDODRINE HCL, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185004001.

Published January 29, 2014 · Recall initiated: July 2, 2013

Summary

FDA records drug Class II recall D-877-2014, published January 29, 2014 and initiated July 2, 2013. Recalling firm: Aidapak Services, LLC; Status: Terminated; Reported quantity: 100 Tablets; Lot: MIDODRINE HCL, Tablet, 2.5 mg has the following codes: Pedigree: W003265, EXP: 6/17/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mixup: MIDODRINE HCL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: PIOGLITAZONE HCL, Tablet, 15 mg, NDC 00093204856, Pedigree: W003264, EXP: 6/17/2014.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Aidapak Services, LLC
Distributor
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Lot
MIDODRINE HCL, Tablet, 2.5 mg has the following codes: Pedigree: W003265, EXP: 6/17/2014.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MIDODRINE HCL, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185004001. recalled?

Yes. FDA published recall D-877-2014 on January 29, 2014. Reported hazard: Labeling: Label Mixup: MIDODRINE HCL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: PIOGLITAZONE HCL, Tablet, 15 mg, NDC 00093204856, Pedigree: W003264, EXP: 6/17/2014.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone